Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

Description

A customer initiates a new account application through various channels, such as in-person at the branch, online, via mobile apps, or through the contact center. Early Warning assesses the probability that the customer is genuine by utilizing our top-notch banking data. This allows for real-time evaluation of identity validity, enhancing the detection of synthetic and altered identities. Additionally, Early Warning forecasts the likelihood that a customer may experience default due to first-party fraud within the initial nine months after opening an account. By applying predictive intelligence, we gain deeper insights into customer behavior. The system also estimates the risk of default stemming from account mismanagement during the same timeframe. Based on these assessments, applicant privileges can be customized to match your institution's risk tolerance. Harnessing real-time predictive analytics facilitates more informed decision-making. This approach not only broadens access for more customers to the conventional financial system but also helps manage risk levels, which could lead to an increase in potential revenue. Ultimately, balancing risk management with customer inclusion is key to fostering a healthier financial ecosystem.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

NuDetect

Integrations

NuDetect

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Altis Labs

Founded

2019

Country

Canada

Website

www.altislabs.com/news/altis-labs-announces-launch-of-nota-a-clinical-information-platform-to-accelerate-therapeutic-r-d

Vendor Details

Company Name

Early Warning

Founded

1990

Country

United States

Website

www.earlywarning.com/products/identity-chek-service-new-account-scores

Product Features

Alternatives

LaunchX Reviews

LaunchX

Nota AI

Alternatives

cidaas Reviews

cidaas

WidasConcepts
Ember Reviews

Ember

MetiStream